Background and Mechanism of Action

NG,NG'-Dimethyl-L-arginine (SDMA) is an endogenously produced symmetric dimethylated derivative of L-arginine. It is generated by post-translational methylation of arginine residues within proteins, catalyzed by type II protein arginine methyltransferases (PRMTs), followed by proteolytic release into circulation.

Unlike its asymmetric counterpart ADMA (asymmetric dimethylarginine), SDMA does not directly inhibit nitric oxide synthase (NOS) at physiologically relevant concentrations. However, SDMA can compete with L-arginine for cellular uptake via cationic amino acid transporters (CATs), potentially influencing intracellular L-arginine availability and indirectly affecting NO production. SDMA is primarily eliminated by renal excretion, making its plasma concentration a sensitive indicator of glomerular filtration rate (GFR) and overall kidney function.

In research settings, SDMA (Aladdin SKU: S413343) is employed as a reference standard for mass spectrometry-based quantification assays, as a tool to study arginine transport competition, and as a biomarker analyte in models of chronic kidney disease (CKD) and cardiovascular disease.

Solution Preparation and Reconstitution

Recommended Solvents: SDMA is a highly polar, water-soluble zwitterionic amino acid derivative. It is readily soluble in water and aqueous buffers (e.g., PBS, physiological saline). Dissolution in DMSO or organic solvents is generally not required and not recommended as a primary solvent.

Step-by-step reconstitution procedure:

1. Allow the vial to equilibrate to room temperature before opening to prevent condensation on the solid compound.
2. Add the appropriate volume of sterile, ultrapure water or aqueous buffer (e.g., PBS, pH 7.4) to achieve the desired stock concentration. A stock concentration of 10–100 mM in water is typically practical.
3. Vortex gently until the compound is fully dissolved. The solution should be clear and colorless.
4. Filter-sterilize the stock solution through a 0.22 µm membrane filter if the solution is intended for cell-based assays.
5. Dispense into single-use aliquots to minimize freeze-thaw cycles.

Note: Verify solubility and recommended concentration ranges with the Certificate of Analysis (CoA) supplied with the product lot.

Experimental Applications and Working Concentrations

SDMA (S413343) is employed across multiple experimental contexts. Representative applications and indicative concentration ranges are provided below. Researchers should optimize concentrations empirically for their specific biological systems.

• Reference standard for LC-MS/MS quantification: SDMA is widely used as an authentic standard for developing and validating mass spectrometry-based assays to measure endogenous SDMA levels in plasma, serum, or urine. Calibration curves are typically prepared in the range of 0.01–10 µM in the relevant biological matrix or surrogate matrix.
• Arginine transport competition assays: SDMA can be used at concentrations of 10 µM to 1 mM to examine competitive inhibition of L-arginine uptake via CAT transporters in cell-based models. Monitor NOS activity or NO production (e.g., Griess assay, DAF fluorescence) as a functional readout.
• Biomarker studies in animal models: Exogenous SDMA administration has been used in rodent models of CKD to supplement or validate endogenous biomarker levels. Dosing and routes of administration should be determined based on peer-reviewed literature relevant to the model used.
• ELISA assay validation: SDMA can serve as a calibration standard for commercial or in-house ELISA-based immunoassays targeting dimethylarginine species.

All working concentrations are indicative. Consult primary literature and validate in your experimental system.

Storage, Stability, and Quality Control

Storage Conditions: Store SDMA (S413343) at -20°C in a tightly sealed container, protected from light and moisture. For long-term storage, desiccation is recommended. Always verify storage conditions with the Certificate of Analysis (CoA) provided with your specific lot.

Stability: As a stable amino acid derivative, SDMA is generally chemically stable when stored under recommended conditions. Aqueous stock solutions may be stored at -20°C for short-to-medium term use; avoid repeated freeze-thaw cycles by using single-use aliquots. Discard solutions showing discoloration, precipitation, or turbidity.

Quality Control:

• Confirm identity and purity using the lot-specific CoA. Typical characterization methods include HPLC, NMR, and MS.
• For quantitative analytical applications, use a certified reference material or isotopically labeled internal standard (e.g., d6-SDMA) alongside S413343 to ensure assay accuracy.
• Perform system suitability testing before analytical runs to confirm instrument performance and standard integrity.

Review the CoA for lot-specific purity data before use in critical experiments.

Safety Considerations and Regulatory Notes

SDMA is an endogenous mammalian metabolite; however, standard laboratory safety precautions must be observed when handling any research reagent.

• Wear appropriate personal protective equipment (PPE): nitrile gloves, lab coat, and safety glasses.
• Avoid inhalation of dust or aerosols when handling the solid form.
• Consult the Safety Data Sheet (SDS) provided by Aladdin Scientific for product-specific hazard information, handling guidance, and disposal requirements prior to use.
• This product (S413343) is supplied for research use only (RUO). It is not approved for human or veterinary diagnostic or therapeutic applications.
• Dispose of waste in accordance with applicable local, national, and institutional regulations.

Always refer to the current lot SDS available from Aladdin Scientific for the most up-to-date safety information.